Eric Adler - Net Worth and Insider Trading

Eric Adler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Adler owns 1 companies in total, including Lexeo Therapeutics Inc (LXEO) .

Click here to see the complete history of Eric Adler’s form 4 insider trades.

Insider Ownership Summary of Eric Adler

Ticker	Comapny	Transaction Date	Type of Owner
LXEO	Lexeo Therapeutics Inc	2023-11-02	Chief Scientific Officer

Eric Adler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric Adler Ownership Network

Ownership Network List of Eric Adler

No Data

Ownership Network Relation of Eric Adler

Eric Adler Owned Company Details

What does Lexeo Therapeutics Inc do?

Who are the key executives at Lexeo Therapeutics Inc?

Eric Adler is the Chief Scientific Officer of Lexeo Therapeutics Inc. Other key executives at Lexeo Therapeutics Inc include director & Chief Executive Officer Richard Nolan Townsend , 10 percent owner Lundbeckfond Invest A/s , and 10 percent owner Omega Fund Vi Gp, L.p. .

Lexeo Therapeutics Inc (LXEO) Insider Trades Summary

Over the past 18 months, Eric Adler made no insider transaction in Lexeo Therapeutics Inc (LXEO). Other recent insider transactions involving Lexeo Therapeutics Inc (LXEO) include a net sale of 80,000 shares made by Richard Nolan Townsend , a net purchase of 454,545 shares made by Longitude Capital Partners Iv, Llc , and a net purchase of 454,545 shares made by Omega Fund Vi Gp, L.p. .

In summary, during the past 3 months, insiders sold 15,000 shares of Lexeo Therapeutics Inc (LXEO) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 80,000 shares of Lexeo Therapeutics Inc (LXEO) were sold and 1,136,362 shares were bought by its insiders, resulting in a net purchase of 1,056,362 shares.

Lexeo Therapeutics Inc (LXEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lexeo Therapeutics Inc Insider Transactions

No Available Data

Eric Adler Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Adler. You might contact Eric Adler via mailing address: C/o Lexeo Therapeutics, Inc., 345 Park Avenue South, 6th Floor, New York Ny 10010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.